Malignant lymphoma subgroups from Zaria, Nigeria, reveal absence of HIV/AIDS-related plasmablastic lymphomas and HHV-8-related lymphoproliferative disorders Yawale Iliyasu 1,3 , Weiqiang Zhao 2,3 , Leona W Ayers 2,3* From 12 th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010 Background Prevalence of non-Hodgkin's lymphoma (NHL) subgroups throughout Africa, particularly among persons with HIV/AIDS, is unknown but increases in Burkitt lymphoma, plasmablastic lymphoma, and HHV-8 proliferation disorders have been noted. SSALC, an AIDS and Cancer Specimen Resource (ACSR/NCI) project, seeks to define indigenous sub-Saharan NHL subtypes using WHO classification (2008) . Omoti (Univ. Benin 2007) defined an overall malignant lymphoma (ML) rate: 13.4/ 100,000 (1990s) including 17% Hodgkin's disease and 83% NHL but subgroups were not defined. Because regional HIV/AIDS prevalence is high, we subgrouped NHL and reviewed lymph node hyperplasia using stored material from Ahmadu Bello University Teaching Hospital in Zaria, Nigeria, to look for HIV/AIDS-associated lymphoid malignancies.
Materials and methods
Fifty-seven paraffin blocks were used to construct a tissue microarray (TMA), and whole tissue sections were H&E stained for morphology. TMA sections were stained 
Results
There were 43 ML and 14 hyperplasic lymph nodes or reactive tissues. One lymph node was suspected for Castleman's disease but Lana-1 was negative. Table 1 lists ML subgroups.
Conclusions
Subgrouping ML with Hodgkin's disease (12%) and NHL (88%) is similar to the 2007 report from nearby Benin University. Burkitt lymphoma was the most common NHL at 51% followed by follicular lymphoma 16% and diffuse large B-cell lymphomas 14%. With the exception of Burkitt lymphoma, which is endemic in Nigeria, other NHL commonly associated with HIV/ AIDS such as plasmablastic lymphoma and HHV-8 lymphoproliferative disorders were not identified.
